MedicinefromSilicon Valley Journals11 hours agoAusperBio Raises $63 Million in Series B2 FinancingAusperBio closed a $63 million Series B2 to fund pivotal development of AHB-137, expand global trials, and advance the Med-Oligo™ ASO platform.